RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

NeurolignFit (mind control device)

Product
Developers: Neurolign
Date of the premiere of the system: September 2021
Branches: Pharmaceuticals, medicine, healthcare

2021: Go to Market

At the end of September 2021, Neurolign, which specializes in clinical eye tracking and neurofunctional diagnosis, released a consumer NeurolignFit device that uses professional eye tracking technology to allow users to track, understand and improve overall mental acuity without leaving home.

Neurolign is at the forefront of technology for brain health, and the release of NeurolignFit is a milestone in the company's mission to introduce neurological training at home and turn brain health into a key part of everyday wellness practice.

A device for controlling mental acuity has arrived on the market NeurolignFit
File:Aquote1.png
The brain, like any other part of the human body, needs training and care, and in the face of the ongoing COVID-19 pandemic, reviving public dialogue about a healthy lifestyle, a product like NeurolignFit is more useful than ever. Until now, the research-confirmed benefits of neurofunctional eye-assisted evaluation have been inaccessible to the general public. Having embodied the capabilities of this technology in an intuitive, gamified consumer device, Neurolign hopes to change people's understanding of the health and well-being of the brain and improve it, "said Eugene Melnid, Chairman and CEO of Neurolign.
File:Aquote2.png

The platform consists of an easy-to-use portable device and mobile application that together use clinical-level eye tracking technology to conduct a series of fast, non-invasive neurological assessments. The data of these tests then pass through an algorithm that creates a constant report on the latest performance of the user's brain in three key areas: mental acuity, concentration, movement. Further, the device offers users a series of eye exercises to train these three areas over time.

File:Aquote1.png
Neurolign's vision tracking technology has been confirmed by 30 patents, 60-plus scientific citations and eight clinical studies in 2020 alone, as well as extensive consultations with colleagues. NeurolignFit is the culmination of our efforts to combine the immense power of clinical vision tracking technology into a consumer-friendly platform. The ability to transfer tools to maintain brain health into the hands of consumers marks a turning point for recovery technologies in general, "commented Alex Kiderman, Neurolign Vice President of Technology Development.
File:Aquote2.png

The technology underlying the NeurolignFit has been developed for more than 30 years by September 2021 and is used in various fields of medicine, due to its ability to determine eye movements associated with more than 200 different diseases and medical conditions. Traditionally, this technology was limited to bulky and expensive devices that could only be used in a professional environment, thus it was transferred to research laboratories and clinical institutions.[1]

Notes